Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00348205 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Safety and Effectiveness of the Technols 217z Zyoptix System for Hyperopia
A NA study of Astigmatism and Hyperopia, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT00348205: Completed NA study of Astigmatism and Hyperopia, sponsored by Bausch & Lomb Incorporated.
NCT00348205 is a NA study of Astigmatism and Hyperopia that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 80 participants, below the 104-participant average among 31 other Astigmatism trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00348205, a NA study of Astigmatism and Hyperopia, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
A study to demonstrate the safety and effectiveness of wavefront laser refractive surgery treatments for hyperopia and astigmatism.
Conditions Studied
Interventions
- DEVICE Technolas 217z Zyoptix Laser
Study Locations (1)
New York
- Bausch & Lomb - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2005-06 |
| Est. Completion | 2009-03 |
| Phase | NA |
What the finished NCT00348205 record still lists
NCT00348205 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 104-participant average among 31 other Astigmatism trials with a reported enrollment target (23% lower).
The record links to 2 conditions, with Astigmatism appearing as the primary indexed condition, and to 1 intervention - of which Technolas 217z Zyoptix Laser is the first listed.
NCT00348205 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00348205 about?
NCT00348205 is a clinical study titled "A Study to Evaluate the Safety and Effectiveness of the Technols 217z Zyoptix System for Hyperopia". A study to demonstrate the safety and effectiveness of wavefront laser refractive surgery treatments for hyperopia and astigmatism.
What is the current status of trial NCT00348205?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2005-06. Estimated completion is 2009-03.
What conditions does trial NCT00348205 study?
This clinical trial studies the following conditions: Astigmatism, Hyperopia.
What interventions are being tested in trial NCT00348205?
The interventions under investigation include: Technolas 217z Zyoptix Laser (DEVICE).
Who is sponsoring clinical trial NCT00348205?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00348205 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Astigmatism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00348205's enrollment target sits among peer trials
80 10th of 31 higher than 22 of 31 other Astigmatism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Astigmatism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery
RECRUITING · NA
-
A Three-Phase Contralateral Comparison of Ray-Tracing Guided LASIK Versus Three Other Refractive Surgery Platforms to Correct Myopia or Myopia With Astigmatism
RECRUITING · NA
-
Contoura With Phorcides Compared to Wavefront Optimized LASIK
RECRUITING · NA
-
Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction
ACTIVE NOT RECRUITING · NA
-
LASIK iDesign vs SMILE
ACTIVE NOT RECRUITING · NA
-
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia